{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:55:00Z","timestamp":1786550100136,"version":"build-2736575974"},"reference-count":89,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1038\/ctg.2016.55","type":"journal-article","created":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T10:43:47Z","timestamp":1477565027000},"page":"e198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["The Cyclic Vomiting Syndrome Threshold: A Framework for Understanding Pathogenesis and Predicting Successful Treatments"],"prefix":"10.14309","volume":"7","author":[{"given":"David J","family":"Levinthal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210317","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2982.2008.01113.x","article-title":"Cyclic vomiting syndrome in adults.","volume":"20","author":"Abell","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"R2-4-20210317","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1741-7015-3-20","article-title":"Cyclic vomiting syndrome in 41 adults: the illness, the patients, and problems of management.","volume":"3","author":"Fleisher","year":"2005","journal-title":"BMC Med"},{"key":"R3-4-20210317","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0140-6736(05)62477-4","article-title":"Cyclic vomiting syndrome and mitochondrial DNA mutations.","volume":"350","author":"Boles","year":"1997","journal-title":"Lancet"},{"key":"R4-4-20210317","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1365-2982.2009.01305.x","article-title":"Are pediatric and adult-onset cyclic vomiting syndrome (CVS) biologically different conditions? Relationship of adult-onset CVS with the migraine and pediatric CVS-associated common mtDNA polymorphisms 16519T and 3010A.","volume":"21","author":"Boles","year":"2009","journal-title":"Neurogastroenterol Motil"},{"key":"R5-4-20210317","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/nmo.12575","article-title":"NextGen nuclear DNA sequencing in cyclic vomiting syndrome reveals a significant association with the stress-induced calcium channel (RYR2).","volume":"27","author":"Lee","year":"2015","journal-title":"Neurogastroenterol Motil"},{"key":"R6-4-20210317","first-page":"103S","article-title":"Mitochondrial disease and cyclic vomiting syndrome.","volume":"44","author":"Boles","year":"1999","journal-title":"Dig Dis Sci"},{"key":"R7-4-20210317","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1007\/s00221-014-3939-4","article-title":"Adult cyclical vomiting syndrome: a disorder of allostatic regulation?","volume":"232","author":"Levinthal","year":"2014","journal-title":"Exp Brain Res"},{"key":"R8-4-20210317","doi-asserted-by":"crossref","first-page":"e1339","DOI":"10.1111\/j.1365-2982.2010.01577.x","article-title":"Autonomic nerve function in adults with cyclic vomiting syndrome: a prospective study.","volume":"22","author":"Venkatesan","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"R9-4-20210317","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2982.2011.01679.x","article-title":"Autonomic nerve function in adult patients with cyclic vomiting syndrome.","volume":"23","author":"Hejazi","year":"2011","journal-title":"Neurogastroenterol Motil"},{"key":"R10-4-20210317","doi-asserted-by":"crossref","first-page":"79S","DOI":"10.1023\/A:1026602216846","article-title":"Cyclic vomiting syndrome: the corticotropin-releasing-factor hypothesis.","volume":"44","author":"Tache","year":"1999","journal-title":"Dig Dis Sci"},{"key":"R11-4-20210317","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1526-4610.2007.00997.x","article-title":"Psychiatric symptoms in children and adolescents with cyclic vomiting syndrome and their parents.","volume":"48","author":"Tarbell","year":"2008","journal-title":"Headache"},{"key":"R12-4-20210317","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1016\/j.jpeds.2015.05.032","article-title":"Anxiety measures predict health-related quality of life in children and adolescents with cyclic vomiting syndrome.","volume":"167","author":"Tarbell","year":"2015","journal-title":"J Pedriatr"},{"key":"R13-4-20210317","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1007\/s00221-014-3967-0","article-title":"An Internet survey of marijuana and hot shower use in adults with cyclic vomiting syndrome (CVS).","volume":"232","author":"Venkatesan","year":"2014","journal-title":"Exp Brain Res"},{"key":"R14-4-20210317","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pediatrneurol.2006.09.008","article-title":"Combined cyclic vomiting syndrome and Kearns-Sayre syndromes.","volume":"26","author":"Boles","year":"2007","journal-title":"Pediatr Neurol"},{"key":"R15-4-20210317","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1526-4610.2003.03078.x","article-title":"Cyclic vomiting syndrome, migraine, and epilepsy: a common underlying disorder?","volume":"43","author":"Cupini","year":"2003","journal-title":"Headache"},{"key":"R16-4-20210317","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/sj.npp.1300506","article-title":"Discovering endophenotypes for major depression.","volume":"29","author":"Hasler","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"R17-4-20210317","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/MPG.0b013e318173ed39","article-title":"North American Society for pediatric gastroenterology, hepatology, and nutrition consensus statement on the diagnosis and management of cyclic vomiting syndrome.","volume":"47","author":"Li","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R18-4-20210317","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2036.2011.04721.x","article-title":"Review article: cyclic vomiting syndrome in adults--rediscovering and redefining an old entity.","volume":"34","author":"Hejazi","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"R19-4-20210317","first-page":"507","article-title":"Cyclic vomiting syndrome: a disorder of all ages.","volume":"5","author":"Sunku","year":"2009","journal-title":"Gastroenterol Hepatol (NY)"},{"key":"R20-4-20210317","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0889-8553(03)00045-1","article-title":"Cyclic vomiting syndrome: a brain-gut disorder.","volume":"32","author":"Li","year":"2003","journal-title":"Gastroenterol Clin North Am"},{"key":"R21-4-20210317","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/j.1526-4610.2008.01277.x","article-title":"The neurogenic basis of migraine.","volume":"48","author":"Cutrer","year":"2008","journal-title":"Headache"},{"key":"R22-4-20210317","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.seizure.2013.03.013","article-title":"Epileptic prodromes: are they nonconvulsive status epilepticus?","volume":"22","author":"Alving","year":"2013","journal-title":"Seizure"},{"key":"R23-4-20210317","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.seizure.2008.10.007","article-title":"Prodromal symptoms in epileptic patients: clinical characterization of the pre-ictal phase.","volume":"18","author":"Scaramelli","year":"2009","journal-title":"Seizure"},{"key":"R24-4-20210317","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.332.7547.951","article-title":"Panic disorder.","volume":"332","author":"Taylor","year":"2006","journal-title":"BMJ"},{"key":"R25-4-20210317","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/da.20603","article-title":"Subtypes of panic attacks: a critical review of the empirical literature.","volume":"26","author":"Kircanski","year":"2009","journal-title":"Depress Anxiety"},{"key":"R27-4-20210317","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1526-4610.2010.01753.x","article-title":"An analysis of migraine triggers in a clinic-based population.","volume":"50","author":"Andress-Rothrock","year":"2010","journal-title":"Headache"},{"issue":"Suppl 1","key":"R28-4-20210317","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/epi.12100","article-title":"The treatment of depressive disorders in epilepsy: what all neurologists should know.","volume":"54","author":"Kanner","year":"2013","journal-title":"Epilepsia"},{"issue":"Suppl 1","key":"R29-4-20210317","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/epi.12101","article-title":"Treatment of anxiety disorders in epilepsy: an evidence-based approach.","volume":"54","author":"Mula","year":"2013","journal-title":"Epilepsia"},{"key":"R30-4-20210317","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.yebeh.2012.09.040","article-title":"Stress, seizures, and hypothalamic-pituitary-adrenal axis targets for the treatment of epilepsy.","volume":"26","author":"Maguire","year":"2013","journal-title":"Epilepsy Behav"},{"key":"R31-4-20210317","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000049326","article-title":"Panic attack as a marker of core psychopathological processes.","volume":"34","author":"Goodwin","year":"2001","journal-title":"Psychopathology"},{"key":"R32-4-20210317","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/psyp.12553","article-title":"Panic disorder with agoraphobia from a behavioral neuroscience perspective: applying the research principles formulated by the Research Domain Criteria (RDoC) initiative.","volume":"53","author":"Hamm","year":"2016","journal-title":"Psychophysiology"},{"key":"R34-4-20210317","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11940-016-0402-9","article-title":"Sleep-related epilepsy.","volume":"18","author":"Carreno","year":"2016","journal-title":"Curr Treat Options Neurol"},{"key":"R35-4-20210317","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.beth.2008.06.001","article-title":"An experimental investigation of the effects of acute sleep deprivation on panic-relevant biological challenge responding.","volume":"40","author":"Babson","year":"2009","journal-title":"Behav Ther"},{"key":"R36-4-20210317","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/head.12725","article-title":"Migraine triggers and oxidative stress: a narrative review and synthesis.","volume":"56","author":"Borkum","year":"2016","journal-title":"Headache"},{"key":"R37-4-20210317","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.yebeh.2015.05.003","article-title":"Pathophysiology of mitochondrial disease causing epilepsy and status epilepticus.","volume":"49","author":"Rahman","year":"2015","journal-title":"Epilepsy Behav"},{"key":"R38-4-20210317","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/head.12640","article-title":"Systematic review of preventive and acute treatment of menstrual migraine.","volume":"55","author":"Nierenburg Hdel","year":"2015","journal-title":"Headache"},{"key":"R39-4-20210317","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1111\/epi.12969","article-title":"Progesterone Trial Study Group. Distribution of seizures across the menstrual cycle in women with epilepsy.","volume":"56","author":"Herzog","year":"2015","journal-title":"Epilepsia"},{"key":"R40-4-20210317","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.cpr.2011.07.006","article-title":"Anxiety sensitivity, the menstrual cycle, and panic disorder: a putative neuroendocrine and psychological interaction.","volume":"31","author":"Nillni","year":"2011","journal-title":"Clin Psychol Rev"},{"key":"R41-4-20210317","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1468-2982.1990.1005263.x","article-title":"Complicated migraine studied by phosphorus magnetic resonance spectroscopy.","volume":"10","author":"Barbiroli","year":"1990","journal-title":"Cephalalgia"},{"key":"R42-4-20210317","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1212\/WNL.42.6.1209","article-title":"Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura.","volume":"42","author":"Barbiroli","year":"1992","journal-title":"Neurology"},{"key":"R43-4-20210317","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1177\/0333102414542662","article-title":"Headache, drugs and sleep.","volume":"34","author":"Nesbitt","year":"2014","journal-title":"Cephalalgia"},{"key":"R44-4-20210317","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.yebeh.2009.01.020","article-title":"Diurnal rhythms in seizures detected by intracranial electrocorticographic monitoring: an observational study.","volume":"14","author":"Hofstra","year":"2009","journal-title":"Epilepsy Behav"},{"key":"R45-4-20210317","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1212\/WNL.0b013e3182553c23","article-title":"Diurnal pattern of seizures outside the hospital: is there a time of circadian vulnerability?","volume":"78","author":"Pavlova","year":"2012","journal-title":"Neurology"},{"key":"R46-4-20210317","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1526-4610.1998.3806436.x","article-title":"Migraine chronobiology.","volume":"38","author":"Fox","year":"1998","journal-title":"Headache"},{"key":"R47-4-20210317","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1526-4610.2012.02165.x","article-title":"Adverse childhood experiences are associated with migraine and vascular biomarkers.","volume":"52","author":"Tietjen","year":"2012","journal-title":"Headache"},{"key":"R48-4-20210317","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.yebeh.2013.09.029","article-title":"Early life stress in epilepsy: a seizure precipitant and risk factor for epileptogenesis.","volume":"38","author":"van Campen","year":"2014","journal-title":"Epilepsy Behav"},{"key":"R49-4-20210317","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1159\/000345358","article-title":"The impact of adverse life events on clinical features and interaction with gene variants in mood disorder patients.","volume":"46","author":"Serretti","year":"2013","journal-title":"Psychopathology"},{"key":"R50-4-20210317","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1528-1167.2011.03361.x","article-title":"A systematic review and meta-analysis of heart rate variability in epilepsy and antiepileptic drugs.","volume":"53","author":"Lotufo","year":"2012","journal-title":"Epilepsia"},{"key":"R51-4-20210317","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jad.2016.04.010","article-title":"The structure and intensity of self-reported autonomic arousal symptoms across anxiety disorders and obsessive-compulsive disorder.","volume":"199","author":"Berle","year":"2016","journal-title":"J Affect Disord"},{"key":"R52-4-20210317","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.seizure.2011.02.012","article-title":"Migralepsy and related conditions: advances in pathophysiology and classification.","volume":"20","author":"Verrotti","year":"2011","journal-title":"Seizure"},{"key":"R53-4-20210317","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.yebeh.2007.08.023","article-title":"Ictal nausea with vomiting as the major symptom of simple partial seizures: Electroencephalographic and magnetoencepalographic analysis.","volume":"11","author":"Sekimoto","year":"2007","journal-title":"Epilepsy Behav"},{"key":"R54-4-20210317","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1523\/JNEUROSCI.0373-15.2015","article-title":"Migraine: multiple processes, complex pathophysiology.","volume":"35","author":"Burstein","year":"2015","journal-title":"J Neurosci"},{"key":"R55-4-20210317","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S1474-4422(15)00198-2","article-title":"New therapeutic approaches for the prevention and treatment of migraine.","volume":"14","author":"Diener","year":"2015","journal-title":"Lancet Neurol"},{"key":"R56-4-20210317","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.neuroscience.2009.11.071","article-title":"Presynaptic 5-HT(1B) receptor-mediated serotonergic inhibition of glutamate transmission in the bed nucleus of the stria terminalis.","volume":"165","author":"Guo","year":"2010","journal-title":"Neuroscience"},{"key":"R57-4-20210317","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(08)61626-8","article-title":"Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.","volume":"372","author":"Ho","year":"2008","journal-title":"Lancet"},{"key":"R58-4-20210317","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1177\/0333102410370878","article-title":"Randomized, controlled trial of telcagepant over four migraine attacks.","volume":"30","author":"Ho","year":"2010","journal-title":"Cephalalgia"},{"key":"R59-4-20210317","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.coph.2015.11.002","article-title":"Modulation of neuronal excitability by immune mediators in epilepsy.","volume":"26","author":"Iori","year":"2016","journal-title":"Curr Opin Pharmacol"},{"key":"R61-4-20210317","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.phrs.2016.04.006","article-title":"Management of genetic epilepsies: from empirical treatment to precision medicine.","volume":"107","author":"Striano","year":"2016","journal-title":"Pharmacol Res"},{"key":"R62-4-20210317","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/19336950.2015.1079674","article-title":"Voltage gated sodium channels as drug discovery targets.","volume":"9","author":"Bagal","year":"2015","journal-title":"Channels (Austin)"},{"key":"R63-4-20210317","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2015.5","article-title":"Targeting voltage-gated calcium channels in neurological and psychiatric diseases.","volume":"15","author":"Zamponi","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"R64-4-20210317","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1124\/mol.115.097998","article-title":"Ionotropic GABA and glutamate receptor mutations and human neurologic diseases.","volume":"88","author":"Yuan","year":"2015","journal-title":"Mol Pharmacol"},{"key":"R65-4-20210317","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nrn3937","article-title":"Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy.","volume":"16","author":"Soltesz","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"R66-4-20210317","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/mp.2015.67","article-title":"Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-.","volume":"21","author":"Baumeister","year":"2016","journal-title":"Mol Psychiatry"},{"key":"R67-4-20210317","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuroscience.2012.07.015","article-title":"Epilepsy: ever-changing states of cortical excitability.","volume":"222","author":"Badawy","year":"2012","journal-title":"Neuroscience"},{"key":"R68-4-20210317","doi-asserted-by":"crossref","first-page":"e74087","DOI":"10.1371\/journal.pone.0074087","article-title":"Interaction between -aminobutyric acid A receptor genes: new evidence in migraine susceptibility.","volume":"8","author":"Quintas","year":"2013","journal-title":"PLoS One"},{"key":"R69-4-20210317","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1038\/npp.2014.92","article-title":"Evidence for linkage and association of GABRB3 and GABRA5 to panic disorder.","volume":"39","author":"Hodges","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"R70-4-20210317","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/phar.1673","article-title":"Effects of medical marijuana on migraine headache frequency in an adult population.","volume":"36","author":"Rhyne","year":"2016","journal-title":"Pharmacotherapy"},{"key":"R71-4-20210317","first-page":"2228","article-title":"Cyclic vomiting: association with multiple homeostatic abnormalities and response to ketorolac.","volume":"91","author":"Pasricha","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"R72-4-20210317","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s11606-013-2624-9","article-title":"Use of a once-daily NSAID in treatment of cyclic vomiting syndrome.","volume":"29","author":"Vidula","year":"2013","journal-title":"J Gen Intern Med"},{"key":"R73-4-20210317","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.janxdis.2013.06.008","article-title":"Sub-threshold panic attacks and agoraphobic avoidance increase comorbidity of mental disorders: results from an adult general population sample.","volume":"27","author":"Pane-Farre","year":"2013","journal-title":"J Anxiety Disord"},{"key":"RU74-4-20210317","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1212\/WNL.0000000000000771","article-title":"Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention.","volume":"83","author":"Ho","year":"2014","journal-title":"Neurology"},{"key":"RU75-4-20210317","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1177\/0333102416653233","article-title":"A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine.","volume":"36","author":"Voss","year":"2016","journal-title":"Cephalalgia"},{"key":"RU76-4-20210317","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12916-015-0522-1","article-title":"New players in the preventive treatment of migraine.","volume":"13","author":"Mitsikostas","year":"2015","journal-title":"BMC Med"},{"key":"RU77-4-20210317","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fphys.2014.00078","article-title":"Involvement of gap junction channels in the pathophysiology of migraine with aura.","volume":"5","author":"Sarrouilhe","year":"2014","journal-title":"Front Physiol"},{"key":"RU78-4-20210317","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/0333102413515348","article-title":"A comparative study of candesartan versus propranolol for migraine prophylaxis: a randomised, triple-blind, placebo-controlled, double cross-over study.","volume":"34","author":"Stovner","year":"2014","journal-title":"Cephalalgia"},{"key":"RU79-4-20210317","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1526-4610.2002.02126.x","article-title":"Olanzapine in the treatment of refractory migraine and chronic daily headache.","volume":"42","author":"Silberstein","year":"2002","journal-title":"Headache"},{"key":"RU80-4-20210317","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1212\/WNL.0000000000001930","article-title":"Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy: a randomized trial.","volume":"85","author":"French","year":"2015","journal-title":"Neurology"},{"key":"RU81-4-20210317","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1212\/WNL.0b013e318278b685","article-title":"Efficacy and safety of ketamine in refractory status epilepticus in children.","volume":"79","author":"Rosati","year":"2012","journal-title":"Neurology"},{"key":"RU82-4-20210317","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1212\/WNL.0b013e3182824e66","article-title":"A randomized controlled trial of intranasal ketamine in migraine with prolonged aura.","volume":"80","author":"Afridi","year":"2013","journal-title":"Neurology"},{"key":"RU83-4-20210317","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.seizure.2015.02.017","article-title":"Experience from therapeutic drug monitoring and gender aspects of gabapentin and pregabalin in clinical practice.","volume":"28","author":"Johannessen-Landmark","year":"2015","journal-title":"Seizure"},{"key":"RU84-4-20210317","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/epi.12028","article-title":"Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months.","volume":"54","author":"Glauser","year":"2013","journal-title":"Epilepsia"},{"key":"RU85-4-20210317","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.eplepsyres.2008.11.010","article-title":"Zonisamide block of cloned human T-type voltage-gated calcium channels.","volume":"83","author":"Matar","year":"2009","journal-title":"Epilepsy Res"},{"key":"RU86-4-20210317","doi-asserted-by":"crossref","first-page":"121ra","DOI":"10.1126\/scitranslmed.3003120","article-title":"T-type calcium channel blockers that attenuate thalamic burst firing and suppress absence seizures.","volume":"4","author":"Tringham","year":"2012","journal-title":"Sci Transl Med"},{"key":"RU87-4-20210317","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1684\/epd.2014.0704","article-title":"The clinical pharmacology of traditional antiepileptic drugs.","volume":"16","author":"Vajda","year":"2014","journal-title":"Epileptic Disord"},{"key":"RU88-4-20210317","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2174\/1871527313666140612125028","article-title":"Current pharmacological interventions in panic disorder.","volume":"13","author":"Freire","year":"2014","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"RU89-4-20210317","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archpsyc.59.7.661","article-title":"Mirtazapine in the treatment of panic disorder.","volume":"59","author":"Carli","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"RU90-4-20210317","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.yebeh.2014.03.021","article-title":"Safety of tianeptine use in patients with epilepsy.","volume":"34","author":"Moon","year":"2014","journal-title":"Epilepsy Behav"},{"key":"RU92-4-20210317","first-page":"CD011004","article-title":"Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis.","volume":"4","author":"Pompoli","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"RU93-4-20210317","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1526-4610.2007.00789.x","article-title":"Effectiveness of yoga therapy in the treatment of migraine without aura: a randomized controlled trial.","volume":"47","author":"John","year":"2007","journal-title":"Headache"}],"container-title":["Clinical and Translational Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ctg201655.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ctg201655","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/01720094-201610000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ctg201655.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:14:29Z","timestamp":1786547669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01720094-201610000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":89,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1038\/ctg.2016.55","relation":{},"ISSN":["2155-384X"],"issn-type":[{"value":"2155-384X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}